Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.
Rassenti
Laura Z
LZ
Moores Cancer Center, University of California, San Diego, CA, USA. lrassenti@popmail.ucsd.edu
Kipps
Thomas J
TJ
D051997:ADP-ribosyl Cyclase 1 / Q000032:analysis* / Q000096:biosynthesis; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000096:biosynthesis; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000378:metabolism; D011237:Predictive Value of Tests; D011379:Prognosis; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000032:analysis* / Q000096:biosynthesis
D014408:Biomarkers, Tumor; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human; D051997:ADP-ribosyl Cyclase 1